1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

BACKGROUND. The prognostic value of 1q21 gain in newly diagnosed multiple myeloma (NDMM) remains controversial. Our aim was to investigate the prognostic value of 1q21 gain in a Chinese population. MATERIALS AND METHODS. We retrospectively identified 565 patients with NDMM from multiple centers in C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Li, Xiaozhe, Chen, Wenming, Wu, Yin, Li, Jianyong, Chen, Lijuan, Fang, Baijun, Feng, Ying, Liu, Junru, Chen, Meilan, Gu, Jingli, Huang, Beihui, Li, Juan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Hematologic Malignancies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853115/
https://ncbi.nlm.nih.gov/pubmed/31455749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados